Charles S. Berkman, SVP, General Counsel & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 38,834 shares at $254.99 ($9.9M) on 2018-09-04, disclosed to the SEC on 2018-09-05.
Open-market sale of $9.9M LGND by SVP, General Counsel & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $254.99 | 19,417 | $5.0M | 50.0% |
| 2 | $254.99 | 19,417 | $5.0M | 50.0% |
| Total | $254.99 avg | 38,834 | $9.9M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $12K | — | Filing → |
| OABI | SELL | 2025-12-09 | $16K | — | Filing → |
| OABI | SELL | 2025-04-07 | $14K | — | Filing → |